Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Respiratory Disease Testing Market Report 2017

  • QYR904518
  • 123 Pages
  • February 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Respiratory Disease Testing

Revenue, means the sales value of Respiratory Disease Testing

This report studies sales (consumption) of Respiratory Disease Testing in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

COSMED

CareFusion Corporation

Carestream Health

Futuremed America

GE Healthcare

MGC Diagnostics Corporation

ndd Medical Technologies

NIHON KOHDEN CORPORATION

Perkin Elmer

Philips Healthcare

SDI Diagnostics

Siemens Healthcare

Smiths Medical

Market Segment by States, covering

California

Texas

New York

Florida

Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Split by applications, this report focuses on sales, market share and growth rate of Respiratory Disease Testing in each application, can be divided into

Application 1

Application 2

Table of Contents

United States Respiratory Disease Testing Market Report 2017

1 Respiratory Disease Testing Overview

1.1 Product Overview and Scope of Respiratory Disease Testing

1.2 Classification of Respiratory Disease Testing

1.2.1 Type I

1.2.2 Type II

1.3 Application of Respiratory Disease Testing

1.3.1 Application 1

1.3.2 Application 2

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Respiratory Disease Testing (2012-2022)

1.4.1 United States Respiratory Disease Testing Sales and Growth Rate (2012-2022)

1.4.2 United States Respiratory Disease Testing Revenue and Growth Rate (2012-2022)

2 United States Respiratory Disease Testing Competition by Manufacturers

2.1 United States Respiratory Disease Testing Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Respiratory Disease Testing Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Respiratory Disease Testing Average Price by Manufactures (2015 and 2016)

2.4 Respiratory Disease Testing Market Competitive Situation and Trends

2.4.1 Respiratory Disease Testing Market Concentration Rate

2.4.2 Respiratory Disease Testing Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Respiratory Disease Testing Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Respiratory Disease Testing Sales and Market Share by States (2012-2017)

3.2 United States Respiratory Disease Testing Revenue and Market Share by States (2012-2017)

3.3 United States Respiratory Disease Testing Price by States (2012-2017)

4 United States Respiratory Disease Testing Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Respiratory Disease Testing Sales and Market Share by Type (2012-2017)

4.2 United States Respiratory Disease Testing Revenue and Market Share by Type (2012-2017)

4.3 United States Respiratory Disease Testing Price by Type (2012-2017)

4.4 United States Respiratory Disease Testing Sales Growth Rate by Type (2012-2017)

5 United States Respiratory Disease Testing Sales (Volume) by Application (2012-2017)

5.1 United States Respiratory Disease Testing Sales and Market Share by Application (2012-2017)

5.2 United States Respiratory Disease Testing Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Respiratory Disease Testing Manufacturers Profiles/Analysis

6.1 COSMED

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Respiratory Disease Testing Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 COSMED Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 CareFusion Corporation

6.2.2 Respiratory Disease Testing Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 CareFusion Corporation Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Carestream Health

6.3.2 Respiratory Disease Testing Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Carestream Health Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Futuremed America

6.4.2 Respiratory Disease Testing Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Futuremed America Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 GE Healthcare

6.5.2 Respiratory Disease Testing Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 GE Healthcare Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 MGC Diagnostics Corporation

6.6.2 Respiratory Disease Testing Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 MGC Diagnostics Corporation Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 ndd Medical Technologies

6.7.2 Respiratory Disease Testing Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 ndd Medical Technologies Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 NIHON KOHDEN CORPORATION

6.8.2 Respiratory Disease Testing Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 NIHON KOHDEN CORPORATION Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Perkin Elmer

6.9.2 Respiratory Disease Testing Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Perkin Elmer Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Philips Healthcare

6.10.2 Respiratory Disease Testing Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Philips Healthcare Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 SDI Diagnostics

6.12 Siemens Healthcare

6.13 Smiths Medical

7 Respiratory Disease Testing Manufacturing Cost Analysis

7.1 Respiratory Disease Testing Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Respiratory Disease Testing

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Respiratory Disease Testing Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Respiratory Disease Testing Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Respiratory Disease Testing Market Forecast (2017-2022)

11.1 United States Respiratory Disease Testing Sales, Revenue Forecast (2017-2022)

11.2 United States Respiratory Disease Testing Sales Forecast by Type (2017-2022)

11.3 United States Respiratory Disease Testing Sales Forecast by Application (2017-2022)

11.4 Respiratory Disease Testing Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Respiratory Disease Testing

Table Classification of Respiratory Disease Testing

Figure United States Sales Market Share of Respiratory Disease Testing by Type in 2015

Table Application of Respiratory Disease Testing

Figure United States Sales Market Share of Respiratory Disease Testing by Application in 2015

Figure United States Respiratory Disease Testing Sales and Growth Rate (2012-2022)

Figure United States Respiratory Disease Testing Revenue and Growth Rate (2012-2022)

Table United States Respiratory Disease Testing Sales of Key Manufacturers (2015 and 2016)

Table United States Respiratory Disease Testing Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Respiratory Disease Testing Sales Share by Manufacturers

Figure 2016 Respiratory Disease Testing Sales Share by Manufacturers

Table United States Respiratory Disease Testing Revenue by Manufacturers (2015 and 2016)

Table United States Respiratory Disease Testing Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Respiratory Disease Testing Revenue Share by Manufacturers

Table 2016 United States Respiratory Disease Testing Revenue Share by Manufacturers

Table United States Market Respiratory Disease Testing Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Respiratory Disease Testing Average Price of Key Manufacturers in 2015

Figure Respiratory Disease Testing Market Share of Top 3 Manufacturers

Figure Respiratory Disease Testing Market Share of Top 5 Manufacturers

Table United States Respiratory Disease Testing Sales by States (2012-2017)

Table United States Respiratory Disease Testing Sales Share by States (2012-2017)

Figure United States Respiratory Disease Testing Sales Market Share by States in 2015

Table United States Respiratory Disease Testing Revenue and Market Share by States (2012-2017)

Table United States Respiratory Disease Testing Revenue Share by States (2012-2017)

Figure Revenue Market Share of Respiratory Disease Testing by States (2012-2017)

Table United States Respiratory Disease Testing Price by States (2012-2017)

Table United States Respiratory Disease Testing Sales by Type (2012-2017)

Table United States Respiratory Disease Testing Sales Share by Type (2012-2017)

Figure United States Respiratory Disease Testing Sales Market Share by Type in 2015

Table United States Respiratory Disease Testing Revenue and Market Share by Type (2012-2017)

Table United States Respiratory Disease Testing Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Respiratory Disease Testing by Type (2012-2017)

Table United States Respiratory Disease Testing Price by Type (2012-2017)

Figure United States Respiratory Disease Testing Sales Growth Rate by Type (2012-2017)

Table United States Respiratory Disease Testing Sales by Application (2012-2017)

Table United States Respiratory Disease Testing Sales Market Share by Application (2012-2017)

Figure United States Respiratory Disease Testing Sales Market Share by Application in 2015

Table United States Respiratory Disease Testing Sales Growth Rate by Application (2012-2017)

Figure United States Respiratory Disease Testing Sales Growth Rate by Application (2012-2017)

Table COSMED Basic Information List

Table COSMED Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Figure COSMED Respiratory Disease Testing Sales Market Share (2012-2017)

Table CareFusion Corporation Basic Information List

Table CareFusion Corporation Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Table CareFusion Corporation Respiratory Disease Testing Sales Market Share (2012-2017)

Table Carestream Health Basic Information List

Table Carestream Health Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Table Carestream Health Respiratory Disease Testing Sales Market Share (2012-2017)

Table Futuremed America Basic Information List

Table Futuremed America Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Table Futuremed America Respiratory Disease Testing Sales Market Share (2012-2017)

Table GE Healthcare Basic Information List

Table GE Healthcare Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Table GE Healthcare Respiratory Disease Testing Sales Market Share (2012-2017)

Table MGC Diagnostics Corporation Basic Information List

Table MGC Diagnostics Corporation Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Table MGC Diagnostics Corporation Respiratory Disease Testing Sales Market Share (2012-2017)

Table ndd Medical Technologies Basic Information List

Table ndd Medical Technologies Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Table ndd Medical Technologies Respiratory Disease Testing Sales Market Share (2012-2017)

Table NIHON KOHDEN CORPORATION Basic Information List

Table NIHON KOHDEN CORPORATION Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Table NIHON KOHDEN CORPORATION Respiratory Disease Testing Sales Market Share (2012-2017)

Table Perkin Elmer Basic Information List

Table Perkin Elmer Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Table Perkin Elmer Respiratory Disease Testing Sales Market Share (2012-2017)

Table Philips Healthcare Basic Information List

Table Philips Healthcare Respiratory Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Table Philips Healthcare Respiratory Disease Testing Sales Market Share (2012-2017)

Table SDI Diagnostics Basic Information List

Table Siemens Healthcare Basic Information List

Table Smiths Medical Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Respiratory Disease Testing

Figure Manufacturing Process Analysis of Respiratory Disease Testing

Figure Respiratory Disease Testing Industrial Chain Analysis

Table Raw Materials Sources of Respiratory Disease Testing Major Manufacturers in 2015

Table Major Buyers of Respiratory Disease Testing

Table Distributors/Traders List

Figure United States Respiratory Disease Testing Production and Growth Rate Forecast (2017-2022)

Figure United States Respiratory Disease Testing Revenue and Growth Rate Forecast (2017-2022)

Table United States Respiratory Disease Testing Production Forecast by Type (2017-2022)

Table United States Respiratory Disease Testing Consumption Forecast by Application (2017-2022)

Table United States Respiratory Disease Testing Sales Forecast by States (2017-2022)

Table United States Respiratory Disease Testing Sales Share Forecast by States (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390